SEC Form 4 · accession 0001209191-16-129545
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott M Rocklage
Director · 10% Owner
Period of report
Jun 22, 2016
Accepted (ET)
Jun 24, 2016 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.22 | Jun 22, 2016 | A | 9,000 | A | — | Jun 21, 2026 | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2017 annual meeting of stockholders.